Explore the heterogeneity of pediatric functional constipation and IBS-C, the limitations of one-size-fits-all algorithms, and the importance of integrating dietary, behavioral, and psychosocial ...
A look back at the latest clinical trial updates for the pediatric population during June 2026. June brought a more concentrated set of clinical trial developments than earlier in the quarter, with ...
New RSV shots and monoclonals cut infant hospitalizations up to 85%, with strong real‑world safety—learn what efficacy vs effectiveness really means. This episode provides a clear-eyed analysis of ...
The AAP recommends swim lessons begin after a child’s first birthday as part of a layered drowning prevention strategy. Drowning deaths are increasing again in the United States, with disproportionate ...
Infant formula safety reaffirmed: Most samples had undetectable or very low contaminant levels, supporting the safety of the US formula supply. Contaminants detected at very low levels: When present, ...
FDA clearance is being sought for roflumilast cream for infants 3 months and older with mild to moderate atopic dermatitis. Arcutis Biotherapeutics has submitted a supplemental new drug application ...
The FDA has approved Avlayah (tividenofusp alfa-eknm) to treat the neurological manifestations of Hunter syndrome in pediatric patients. In a phase 1/2 clinical trial, the treatment led to a 91% ...
FDA okays once-weekly navepegritide for children with achondroplasia, boosting growth with strong trial data; rollout expected early Q2 2026. The US Food and Drug Administration (FDA) has approved ...
Intravenous gadopiclenol (Vueway; Bracco) is now approved for use in infants and neonates, extending its indication to the youngest patient populations. Gadopiclenol provides high-quality contrast ...
Nearly 1 in 5 US youths aged 2 to 19 years had obesity in 2024, with rates of overweight or obesity increasing with age and reaching 38.5% among adolescents aged 12 to 19 years. Significant racial and ...
New dietary guidelines stress whole foods and reduced processing, with expanded, age-specific guidance for infants, children, and adolescents. According to the agencies, the updated guidelines respond ...
The FDA approved narsoplimab-wuug as the first targeted treatment for transplant-associated thrombotic microangiopathy in adults and children. On December 24, 2025, the FDA approved narsoplimab-wuug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results